Mechanistic connections between transcription and splicing are strong and recent studies have reported that elevated cMYC levels increase the sensitivity of cancer cells to splicing inhibition24,25, suggesting the possibility that high levels of transcription require high levels of splicing; this connection could be one of the main reasons for the higher sensitivity of tumors to SF3B1 inhibition. Here, MYC is linked to cancer.